Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are enzymes that belong to the neuromuscular cholinergic system, their main function is to hydrolyze the neurotransmitter acetylcholine (ACh), through their hydrolysis these enzymes regulate the neuronal and neuromuscular cholinergic system. They have recently attracted considerable attention due to the discovery of new enzymatic and nonenzymatic functions. These discoveries have aroused the interest of numerous scientists, consolidating the relevance of this group of enzymes. Recent investigations have revealed a positive correlation between several risk factors for metabolic syndrome (MetS) and the expression of cholinesterases (ChE's), which underscore the impact of high ChE's activity on the pro‐inflammatory state associated with MetS. In addition, the excessive hydrolysis of ACh and other choline esters (succinylcholine, propionylcholine, butyrylcholine, etc.) by both ChE's results in the overproduction of fatty acid precursor metabolites, which facilitate the synthesis of very low‐density lipoproteins and triacylglycerols. Participation in these processes may represent the link between ChE's and metabolic disorders. However, further scientific research is required to fully elucidate the involvement of ChE's in metabolic diseases. This review aims to collect recent research studies that contribute to understanding the association between the cholinergic system and metabolic diseases.
19 April 2021 in International Journal of Occupational Safety and Health
The pandemic caused by COVID-19 has grown exponentially from the first reports from China in December 2019 to November 2020. Cases have been reported in more than 180 countries, totaling more than 61.8 million cases of COVID-19 throughout the world and more than 1.4 million deaths. Health personnel, being exposed to the care of COVID-19 patients with high viral load, have the risk of developing infections associated with health care, their high morbidity and mortality being of multifactorial origin. Given that the term Biosafety and Occupational Biosafety has been used internationally, this term does not have wide acceptance in the scientific community and in the case of Mexico it is not referred to and it is not defined in the Mexican legal framework or current regulations. Far from being handled and understood as an isolated concept, this term should be referred to as multiple concepts, being recommended in the workplace in Mexico not to use it, suggesting referring to the Safety and Health Regulations at Work, whose mandatory application will allow reducing healthcare-associated infections.
Diabetic retinopathy (DR) is a major complication of diabetes mellitus. Growing evidence shows that hyperglycemia causes not only microvascular damage but also retinal neural dysfunction. Although different metabolic pathways have been implicated, the exact mechanism behind retinal degeneration remains unclear. Hyperglycemic stimuli have been shown to reduce the function of the retinal blood–barrier (BRB) in both diabetic humans and animals. As part of the BRB, the retinal pigment epithelium (RPE) plays a key role in retinal function by regulating the flow of metabolites and ions between the choroidal blood supply and the outer retina, and by supporting photoreceptor cell functions. Therefore, RPE dysfunction can lead to retinal injury. To understand the role of RPE in DR, we studied oxidative stress in the RPE at the early onset of streptozotocin‐induced diabetes in rats. We found a 60% increase in lipoperoxidation at 45 days of diabetes, along with a 50% reduction in ascorbic acid content. Oxidized proteins were significantly increased after 20 and 45 days of diabetes induction, and changes in cell–cell contacts were observed. Despite these findings, superoxide dismutase activity was greatly increased at 45 days of diabetes, while Nrf2 expression and levels of total and reduced glutathione, key regulators of cellular antioxidant capacity, were similar in control and diabetic rat RPE. Moreover, the increase in oxidized proteins was not affected by the antioxidant quercetin nor by the NOS inhibitor L‐NAME. These findings suggest that protein carbonylation may impair protein function or turnover, which in turn leads to RPE damage.
A hypercaloric diet is associated with oxidative stress and the dysfunction of ATP-Binding Cassette transporter A1 (ABCA1), a key element in high-density lipoprotein (HDL) biogenesis and reverse cholesterol transport. Nicotinamide (NAM) presents antioxidant properties, which may contribute to maintaining lipid metabolism. Therefore, we aimed to evaluate the effect of NAM on HDL-cholesterol (HDL-C) level, oxidative stress markers, and the gene expression and protein levels of ABCA1 in Sprague-Dawley rats fed a hypercaloric diet. Forty male rats were divided into five groups: one group received a standard diet, and the remaining groups received a single high-fat, high-fructose diet (HFDF). Three of the HFDF groups received NAM treatment (5, 10, and 15 mM) in drinking water for 16 weeks (5 h/day). While HDL-C and oxidative stress were measured in serum samples, oxidative stress markers, and the gene expression and protein levels of ABCA1 were quantified in liver samples. The HDL-C level altered by the HFDF was improved by treatment with NAM. Furthermore, NAM reduces systemic lipid peroxidation levels and enhances the hepatic antioxidant response affected by the HFDF. In addition, NAM modulates the hepatic ABCA1 gene expression and protein level, altered by the HFDF. Our results suggest that NAM may modify the serum HDL-C level by an improvement of antioxidant response, and a possible modulation of the hepatic ABCA1 gene and protein expression. Further metabolic and molecular studies are needed to support the potential therapeutic role of NAM to prevent or treat lipid alterations promoted by a hypercaloric diet.